$14.84
+0.0 (+0.0%)
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$2.2B
ROE
-94.5%
D/E
6.93
Beta
0.07
52W
$4–$15
Wall Street Consensus
11 analysts · Mar 20263
Strong Buy
5
Buy
3
Hold
0
Sell
0
Strong Sell
72.7%
Buy Rating
Price Chart
Similar Stocks
GRAL
Grail Inc
$3.3B
RLAY
Relay Therapeutics Inc
$1.5B
MLYS
Mineralys Therapeutics Inc
$2.9B
SNDX
Syndax Pharmaceuticals Inc
$1.8B
DAWN
Day One Biopharmaceuticals Inc
$956.9M
ADMA
ADMA Biologics Inc
P/E 20.7
$4.3B
RARE
Ultragenyx Pharmaceutical Inc
$2.2B
TYRA
Tyra Biosciences Inc
$1.4B
CLDX
Celldex Therapeutics Inc
$1.8B
AGIO
Agios Pharmaceuticals Inc
$1.6B
Earnings
Beat rate: 25.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Jun 2025 | $-0.50 | $-0.71 | $-0.21 |
| Mar 2025 | $-0.51 | $-0.49 | +$0.02 |
| Dec 2024 | $-0.79 | $-1.02 | $-0.23 |
| Sep 2024 | $-0.65 | $-1.39 | $-0.74 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -94.5% | -94.5% | -94.5% | -94.5% | -94.5% | -94.5% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 6.93 | 6.93 | 6.93 | 6.93 | 6.93 | 6.93 |
| Current Ratio | 15.19 | 15.19 | 15.19 | 15.19 | 15.19 | 15.19 |
Key Ratios
ROA (TTM)
-80.9%
P/B
2.3
EPS (TTM)
$-3.61
CF/Share
$-1.99
52W High
$15.06
52W Low
$4.16
$4.16
52-Week Range
$15.06
How does ETNB compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
ETNB valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
2.3
▼
7%
below
peers
(2.5)
vs Peers
vs Industry
Fair value
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
ETNB profitability vs Biotechnology peers
ROE
-94.5%
▼
40%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-80.9%
▼
73%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
ETNB financial health vs Biotechnology peers
D/E ratio
6.9
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
15.2
▲
242%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
0.1
▼
93%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
ETNB fundamentals radar
ETNB
Peer median
Industry
ETNB profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
ETNB vs peers: key metrics
Latest News
No related news yet